How does vaping or electronic cigarette use affect anesthesia management and peri‑operative outcomes?

Vaping and E-Cigarette Use: Critical Anesthesia Considerations

Patients who vape or use e-cigarettes should be treated identically to traditional cigarette smokers for perioperative management, with cessation recommended for at least 4 weeks before elective surgery to reduce respiratory and wound-healing complications.

Preoperative Assessment and Screening

Routine screening for vaping/e-cigarette use is essential during preoperative evaluation 1. When assessing these patients, specifically document:

• Frequency of use (times per day)
• Type of product (nicotine-based, THC/cannabis-containing, or both)
• Duration of use (weeks, months, years)
• Time of last use before surgery 1
• Presence of respiratory symptoms (cough, dyspnea, chest pain)

Risk Stratification

E-cigarette users face multiple perioperative risks that mirror and potentially exceed traditional smoking:

Respiratory System Effects:

• Acute lung injury (EVALI - E-cigarette or Vaping Product Use-Associated Lung Injury) 2
• Airway hyperreactivity and bronchospasm 3
• Impaired mucociliary clearance
• Increased risk of postoperative respiratory complications 4

Cardiovascular Effects:

• Nicotine-induced tachycardia and hypertension 5
• Increased myocardial oxygen demand
• Potential for coronary vasospasm 1
• Elevated risk of perioperative cardiac events 4

Wound Healing Impairment:

• Delayed tissue regeneration 6
• Increased surgical site infections
• Compromised microvascular blood flow 6

Preoperative Optimization

Cessation Recommendations

For elective surgery, vaping/e-cigarette cessation should occur at least 4 weeks preoperatively 7, 8. This timeline is based on established smoking cessation evidence, as current guidelines explicitly recommend treating e-cigarettes like traditional tobacco products 7.

Key cessation strategies:

• Intense counseling combined with nicotine replacement therapy (NRT) is most effective 7
• Avoid abrupt cessation within 24 hours of surgery if patient is a heavy user 1
• For cannabis-containing products, consider tapering if consuming >1.5 g/day inhaled or >20 mg/day THC oil 1

Important Caveat

While 4-8 weeks of abstinence is ideal for reducing respiratory and wound complications 7, 8, the evidence for short-term cessation (<4 weeks) remains unclear 7. However, even shorter periods may yield some benefits 7.

Intraoperative Management

Anesthetic Technique Selection

Regional anesthesia should be strongly considered when feasible 1. This approach:

• Minimizes respiratory depression
• Reduces opioid requirements
• Avoids airway manipulation in potentially reactive airways

For general anesthesia:

• Secure the airway definitively rather than relying on deep sedation 9
• Plan for awake extubation when medically appropriate 9
• Verify complete neuromuscular blockade reversal before extubation 9

Pharmacologic Considerations

Cannabis/THC users may demonstrate:

• Tolerance to propofol - may require higher induction doses 4
• Reduced opioid efficacy - consider multimodal analgesia 4
• Altered response to sedatives - titrate carefully 4

Nicotine effects:

• Sympathetic stimulation may increase anesthetic requirements
• Potential for hemodynamic instability 5

Airway Management

Anticipate increased airway reactivity:

• Have bronchodilators immediately available
• Consider deeper anesthesia before airway instrumentation
• Use smooth, gentle technique for laryngoscopy
• Consider lidocaine pretreatment to blunt airway reflexes

Postoperative Considerations

Enhanced Monitoring

Vaping patients require vigilant respiratory monitoring 2:

• Continuous pulse oximetry
• Frequent respiratory rate assessment
• Early identification of respiratory distress
• Lower threshold for supplemental oxygen

Pain Management Strategy

Implement multimodal analgesia given potential opioid tolerance in cannabis users 4:

• Regional techniques (peripheral nerve blocks, neuraxial anesthesia)
• Non-opioid analgesics (acetaminophen, NSAIDs, gabapentinoids)
• Ketamine infusions for severe pain
• Opioids as adjunct rather than primary therapy

Wound Care Vigilance

Monitor surgical sites closely for signs of impaired healing 6:

• Increased infection risk
• Delayed wound closure
• Dehiscence potential

Special Population: Cannabis/THC Vapers

For patients vaping cannabis products 1:

• Screen for Cannabis Use Disorder (CUD) if using >2-3 times daily
• Minimum 3-day abstinence for elective surgery (ideally 2 weeks for airway irritability reduction)
• Document THC/CBD content when possible
• Consider addiction medicine consultation for heavy users
• Risk of withdrawal - do not abruptly stop <24 hours before surgery

Critical Clinical Pitfalls

1. Don't assume e-cigarettes are "safer" - treat them as equivalent to traditional smoking for perioperative risk 7, 8

2. Don't miss EVALI - acute respiratory symptoms in vapers may represent severe lung injury requiring ICU-level care 2

3. Don't underestimate anesthetic requirements - cannabis users may need significantly higher doses of sedatives and analgesics 4

4. Don't forget cardiovascular risks - nicotine causes real hemodynamic effects regardless of delivery method 5

5. Don't overlook wound healing - vaping impairs tissue regeneration as much as traditional smoking 6

When Guidelines Are Silent

The provided guidelines address traditional smoking extensively but lack specific e-cigarette protocols 7. In this evidence gap, the consensus approach is clear: apply traditional smoking guidelines to vaping patients 7, 8. This conservative strategy prioritizes patient safety given emerging evidence of equivalent or greater harm from e-cigarettes 2, 3, 6.

The bottom line: Vaping is not a safe alternative to smoking from a perioperative perspective, and patients should be counseled and managed accordingly.